NOUVELLE PHARMACIE DE BELLEVUE : revenue, balance sheet and financial ratios

NOUVELLE PHARMACIE DE BELLEVUE is a French company founded 11 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in FORT-DE-FRANCE (97200), this company of category PME shows in 2021 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NOUVELLE PHARMACIE DE BELLEVUE (SIREN 808584064)
Indicator 2025 2024 2023 2021 2019 2018 2017 2016
Revenue N/C N/C N/C 1 024 668 € 878 128 € 841 174 € 770 991 € 834 510 €
Net income -42 435 € -170 486 € -36 199 € 24 446 € 40 087 € 10 514 € -2 266 € 31 274 €
EBITDA N/C N/C N/C 30 873 € 55 974 € 19 354 € 17 914 € 76 500 €
Net margin N/C N/C N/C 2.4% 4.6% 1.2% -0.3% 3.7%

Revenue and income statement

Im Jahr 2025 verzeichnet NOUVELLE PHARMACIE DE BELLEVUE einen Nettoverlust von 42 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-42 435 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt -734%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht -9%. Geringe Autonomie: Das Unternehmen ist stark von externer Finanzierung abhängig.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-734.407%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-9.081%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

77.6%

Solvency indicators evolution
NOUVELLE PHARMACIE DE BELLEVUE

Sector positioning

Verschuldungsgrad
-734.41 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Ausgezeichnet -50 pts over 3 years

Im Jahr 2025 liegt in den unteren 25% der Branche, was positiv ist das verschuldungsgrad von NOUVELLE PHARMACIE DE BEL... (-734.41). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Ein niedriges Verhältnis zeigt eine solide Finanzstruktur mit geringer Abhängigkeit von Gläubigern.

Finanzielle Autonomie
-9.08% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Beobachten

Im Jahr 2025 liegt in den unteren 25% der Branche das finanzielle autonomie von NOUVELLE PHARMACIE DE BEL... (-9.1%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Geringe Autonomie kann die Investitionsfähigkeit einschränken und die Verwundbarkeit erhöhen.

Liquidity ratios

Die Liquiditätsquote beträgt 62.22. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

62.224

Liquidity indicators evolution
NOUVELLE PHARMACIE DE BELLEVUE

Sector positioning

Liquiditätsquote
62.22 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Beobachten -9 pts over 3 years

Im Jahr 2025 liegt in den unteren 25% der Branche das liquiditätsquote von NOUVELLE PHARMACIE DE BEL... (62.22). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis unter 1 kann auf potenzielle Liquiditätsspannungen hinweisen.

Working capital requirement (WCR) and payment terms

Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
NOUVELLE PHARMACIE DE BELLEVUE

Positioning of NOUVELLE PHARMACIE DE BELLEVUE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare NOUVELLE PHARMACIE DE BELLEVUE with other companies in the same sector:

Frequently asked questions about NOUVELLE PHARMACIE DE BELLEVUE

What is the revenue of NOUVELLE PHARMACIE DE BELLEVUE ?

The revenue of NOUVELLE PHARMACIE DE BELLEVUE in 2021 is 1.0 M€.

Is NOUVELLE PHARMACIE DE BELLEVUE profitable?

NOUVELLE PHARMACIE DE BELLEVUE recorded a net loss in 2025.

Where is the headquarters of NOUVELLE PHARMACIE DE BELLEVUE ?

The headquarters of NOUVELLE PHARMACIE DE BELLEVUE is located in FORT-DE-FRANCE (97200), in the department Martinique.

Where to find the tax return of NOUVELLE PHARMACIE DE BELLEVUE ?

The tax return of NOUVELLE PHARMACIE DE BELLEVUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NOUVELLE PHARMACIE DE BELLEVUE operate?

NOUVELLE PHARMACIE DE BELLEVUE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.